NZ206293A - (n-(2-chloroethyl)-n-nitrosoureido)-methyl phosphonic acid derivatives and pharmaceutical compositions - Google Patents

(n-(2-chloroethyl)-n-nitrosoureido)-methyl phosphonic acid derivatives and pharmaceutical compositions

Info

Publication number
NZ206293A
NZ206293A NZ206293A NZ20629383A NZ206293A NZ 206293 A NZ206293 A NZ 206293A NZ 206293 A NZ206293 A NZ 206293A NZ 20629383 A NZ20629383 A NZ 20629383A NZ 206293 A NZ206293 A NZ 206293A
Authority
NZ
New Zealand
Prior art keywords
chloroethyl
general formula
radical
exchangeable
nitrosoureido
Prior art date
Application number
NZ206293A
Other languages
English (en)
Inventor
G Lavielle
C Cudennec
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NZ206293A publication Critical patent/NZ206293A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NZ206293A 1982-11-17 1983-11-16 (n-(2-chloroethyl)-n-nitrosoureido)-methyl phosphonic acid derivatives and pharmaceutical compositions NZ206293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8219199A FR2536075B1 (fr) 1982-11-17 1982-11-17 Nouveaux derives de la nitrosouree, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
NZ206293A true NZ206293A (en) 1987-02-20

Family

ID=9279241

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ206293A NZ206293A (en) 1982-11-17 1983-11-16 (n-(2-chloroethyl)-n-nitrosoureido)-methyl phosphonic acid derivatives and pharmaceutical compositions

Country Status (19)

Country Link
US (1) US4567169A (da)
EP (1) EP0117959B1 (da)
JP (1) JPS59106497A (da)
AT (1) ATE21905T1 (da)
AU (1) AU557139B2 (da)
CA (1) CA1204442A (da)
DE (1) DE3365900D1 (da)
DK (1) DK169340B1 (da)
ES (1) ES8501772A1 (da)
FR (1) FR2536075B1 (da)
IE (1) IE56259B1 (da)
IL (1) IL70253A (da)
MA (1) MA19952A1 (da)
NO (1) NO163409C (da)
NZ (1) NZ206293A (da)
OA (1) OA07589A (da)
PT (1) PT77666B (da)
SU (1) SU1303024A3 (da)
ZA (1) ZA838558B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2567129B1 (fr) * 1984-07-06 1986-12-05 Adir Nouveaux derives de l'oxaazaphosphorine, leur procede de preparation et les compositions pharmaceutiques les renfermant
IT1246778B (it) * 1991-04-12 1994-11-26 Boehringer Mannheim Italia Nitrosocarbamoil derivati di acidi gem-difosfonici, un processo per la loro preparazione e composizioni farmaceutiche che li contengono
US5298499A (en) * 1991-07-05 1994-03-29 Research Triangle Institute S-2-(substituted ethylamino)ethyl phosphorothioates
WO1997018819A1 (en) * 1995-11-20 1997-05-29 Sepracor, Inc. Antineoplastic methods and compositions employing optically pure (-)-fotemustine
JP2000500495A (ja) * 1995-11-20 2000-01-18 セプラコール,インク. (+)−フォテムスチンを用いる新生物を治療するための方法および組成物
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
CN100365002C (zh) * 2004-06-02 2008-01-30 上海医药科技发展有限公司 注射用福莫司汀制备工艺
AT501496B1 (de) * 2005-02-21 2007-03-15 Iep Gmbh Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen
CN102311456A (zh) * 2011-07-08 2012-01-11 山东睿鹰先锋制药有限公司 一种福莫司汀原料药的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920733A (en) * 1973-08-06 1975-11-18 Monsanto Co Ureidoalkylphosphonic acids

Also Published As

Publication number Publication date
DK524283D0 (da) 1983-11-16
FR2536075A1 (fr) 1984-05-18
ES527353A0 (es) 1984-12-01
ES8501772A1 (es) 1984-12-01
PT77666B (fr) 1986-05-12
AU557139B2 (en) 1986-12-04
IE832680L (en) 1984-05-17
NO163409B (no) 1990-02-12
ATE21905T1 (de) 1986-09-15
DK524283A (da) 1984-05-18
ZA838558B (en) 1984-07-25
FR2536075B1 (fr) 1985-07-05
SU1303024A3 (ru) 1987-04-07
IL70253A (en) 1986-10-31
EP0117959B1 (fr) 1986-09-03
EP0117959A2 (fr) 1984-09-12
JPS59106497A (ja) 1984-06-20
CA1204442A (fr) 1986-05-13
IE56259B1 (en) 1991-06-05
AU2143683A (en) 1984-05-24
JPS6411637B2 (da) 1989-02-27
NO834214L (no) 1984-05-18
OA07589A (fr) 1985-03-31
MA19952A1 (fr) 1984-07-01
PT77666A (fr) 1983-12-01
DK169340B1 (da) 1994-10-10
IL70253A0 (en) 1984-02-29
NO163409C (no) 1990-05-23
DE3365900D1 (en) 1986-10-09
US4567169A (en) 1986-01-28
EP0117959A3 (en) 1984-11-14

Similar Documents

Publication Publication Date Title
SU1333240A3 (ru) Способ получени производных метилендифосфоновой кислоты
US5840716A (en) Phosphonate nucleotide compounds
EP0717736B1 (en) Phosphorus derivatives to treat aids
EP0559079B1 (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
NZ206293A (en) (n-(2-chloroethyl)-n-nitrosoureido)-methyl phosphonic acid derivatives and pharmaceutical compositions
FR2528048A1 (fr) Amidines de la famille des mitosanes et leur application pharmacologique
AU3760793A (en) Antiviral phosphonic acid derivatives of purine analogues
AU742881B2 (en) Bisaryl compounds and cancer remedies containing the same
DK168386B1 (da) N-(23-vinblastinoyl)derivater af 1-aminomethylphosphonsyre og en fremgangsmåde til deres fremstilling
JP3045354B2 (ja) チオキサンテノン類およびその抗腫瘍剤
JP2742568B2 (ja) 燐酸マイトマイシン誘導体
US6468992B1 (en) Phosphonic acid diester derivatives
CH681624A5 (da)
Perlman et al. Synthesis, molecular symmetry, and chemical reactivity of C-aryl-substituted phosphoraziridines
JPH05262760A (ja) チオキサンテノン類およびその抗腫瘍剤
Wu et al. ASYMMETRIC SYNTHESIS OF (Rp)-AND (Sp)-2-ETHYL-,(Rp)-2-PENTYLOXY-,(Sp)-2-PENTYLTHIO-AND (Sp)-2-PENTYLAMINO-4 H-1, 3, 2-BENZODIOXAPHOSPHORIN 2-OXIDES
JPH0633293B2 (ja) 置換されたヒドロキシ−ヘテロシクリル−アルコキシホスフイニルオキシ−トリアルキルアミニウムヒドロキシド分子内塩オキシド類、それらの製造方法および医薬品としてのそれらの使用
JPS6348877B2 (da)
CS185191A3 (en) Enantiomers of 2-tetrahydrofuran derivatives, intermediates of said compounds and process for preparing thereof
CS208780B2 (en) Method of making the new aminoderovatives of the 2-methyl-5/2-hydroxystyryl/-1,2,4-thiadiazole
NL8303293A (nl) Aminoglycoside derivaten en werkwijzen voor het bereiden van deze derivaten en hun toepassing.
PL121560B1 (en) Process for preparing novel derivatives of xylitol

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: LES LABORATOIRES SERVIER, FR

Free format text: OLD OWNER(S): ADIR